TY  - JOUR

T1  - Pharmacodynamic and Clinical Results from a Phase I/II Study of the HSP90 Inhibitor Onalespib in Combination with Abiraterone Acetate in Prostate Cancer

JO  - Clinical Cancer Research

PY  - -0001/11/30

AU  - Slovin S

AU  - Hussain S

AU  - Saad F

AU  - Garcia J

AU  - Picus J

AU  - Ferraldeschi R

AU  - Crespo M

AU  - Flohr P

AU  - Riisnaes R

AU  - Lin C

AU  - Keer H et al

ED  - 

DO  - DOI: 10.1158/1078-0432.ccr-18-3212

PB  - American Association for Cancer Research (AACR)

VL  - 25

IS  - 15

SP  - 4624

EP  - 4633

Y2  - 2024/12/26

ER  -